Private Placement

A new subcontract for AI edge systems, backed by key industry investors, highlights a major shift toward real-time, autonomous intelligence on the battlefield.

The company launches Artemis, an AI to unify sales tech, and introduces the Forward Deployed AE, a new role to ensure the technology actually works for humans.

A new $175M Indiana facility from a Kratos-RAFAEL venture breaks ground, aiming to fix a critical national security vulnerability in U.S. rocket motor production.

BitGo and New Frontier Labs are launching FYUSD, a stablecoin bringing U.S. regulatory standards to Asia and paving the way for AI-driven finance.

Singapore's Strutt Inc. sees unprecedented demand for its ev¹ Smart Everyday Vehicle. Now, the company faces the ultimate test: scaling up to deliver.

enGene hits the road for key investor conferences, showcasing a promising non-viral gene therapy for a tough-to-treat bladder cancer. Will it succeed?

The biotech firm landed $1M at a premium, a sign of investor faith. But with past regulatory hurdles, can this cash pave a new path for its NurOwn® therapy?

The junior explorer secures crucial funding from a renowned investor, fueling its nickel-copper ambitions in Canada's critical mineral heartland.

As Europe's landmark MiCAR regulation takes hold, KuCoin EU expands its Vienna compliance team, signaling a strategic shift toward regulated growth.

Sai Life Sciences' plan to hire 700+ professionals underscores a global shift, positioning India as a critical hub for pharmaceutical R&D and manufacturing.

Telehealth firm MangoRx reports explosive growth with its $99/month TRT program, challenging competitors and raising questions about the future of virtual care.

A new investment aims to bolster NYC's grid with battery storage, but developers face a charged debate between climate goals and community safety fears.

Aventura Private Wealth closes its second Anduril offering, signaling a major shift as private capital floods into high-tech defense disruptors.

MARBLEX's ambitious AI-powered MMO aims to redefine creation, but past criticisms and technical hurdles cast a shadow on its grand vision for Steam.

INmune Bio will present key Phase III results for CORDStrom, a systemic cell therapy for the devastating rare skin disease RDEB. Will it be a breakthrough?

CorroHealth's CPO Becky Blake earns a top leadership award, shining a light on the crucial, yet complex, role of HR in fueling rapid health tech growth.

Klothea Bio's trial for a 'longevity protein' drug in Honduras pushes the boundaries of science, but raises questions about offshore research and equity.

A new fund combines nuclear energy and AI tech, betting that one can solve the other's massive power problem. But is it a brilliant strategy or a risky gamble?

A new service promises to decode and counter viral misinformation in 24 hours, offering brands a rapid-response weapon in the age of digital deception.

A new partnership between USGBC California and Green Badger aims to eliminate the paperwork nightmare of green building, making sustainability truly scalable.